The FDA Is Struggling To Police The Peptide Boom
Unlike FDA-approved peptide medicines, many compounds marketed online have never undergone rigorous clinical testing or regulatory review. That leaves fundamental questions about their safety and effectiveness unanswered. The bigger challenge is the…















